Status: Recruiting
Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service.
An open longitudinal observational study, non-randomized, which will include the adult population, attended by the SES, in which preference will be given to those patients under treatment with drugs that can produce relevant adverse effects. It is a naturalistic study in which no pharmacological or other type of intervention will be carried out, only the information recommended in the drug data sheet (pharmacogenetic biomarkers, relevant interactions and clinical contraindications) will be provided.
Participants needed: 6,445
Trial details
Biological sex: AllType: ObservationalSponsor: Complejo Hospitalario Universitario de BadajozUpdated: Sep 23, 2024Locations: 1Duration: 1 Year
Eligibility criteria
If the minor is under 12 years of age, participation will require the consent an... [+3]
Failure to meet any of the inclusion criteria described above. [+2]